Abstract
Introduction
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder characterized by chronic inflammation in the gastrointestinal tract [1] . IBD affects approximately 0.1% of the population and consists of two main disease types; Crohn's disease (CD) and ulcerative colitis (UC). Both CD and UC can reduce quality of life [2] . Although there is still a limited understanding of the pathogenesis for CD and UC, current evidence suggests IBD is a multifactorial disease determined by several factors including genetics, environmental factors, and microbial content [3] [4] [5] [6] . In addition, findings from familial aggregation and twin studies have shown that genetic factors are an important component involved in IBD susceptibility [7, 8] . Recent reports have shown genetic sequence variations such as mutations in IL23R are associated with IBD [9] [10] [11] .
Glutathione S-transferases (GSTs) are important enzymes involved in the detoxification of endogenous or exogenous compounds such as reactive oxygen species (ROS) [12, 13] . The null genotype of the Glutathione S-transferase T1 (GSTT1) gene causes a homozygous deletion that leads to decreased activity of the GST enzyme [14] . The GSTT1 null genotype can decrease GST enzyme activity and cause oxidative stress, which may enhance the risk of IBD [15, 16] . Several studies have investigated the association between the GSTT1 null genotype and susceptibility to IBD. However, the studies have reported conflicting results [17] [18] [19] [20] [21] [22] . Duncan et al. showed the GSTT1 null genotype increased UC susceptibility but was not associated with CD [17] . Conversely, Karban et al. reported the GSTT1 null genotype increased susceptibility to CD but not UC [20] . Ernst et al. reported the GSTT1 null genotype was not associated with UC or CD [19] . Previous studies also reported conflicting findings on the association between the GSTT1 null genotype and IBD [18, [21] [22] [23] [24] . Therefore, we conducted a meta-analysis of observational studies to evaluate the association.
Materials and Methods

Literature search and eligibility of studies
We searched the following resources to identify eligible studies: PubMed, Embase, Web of Science, Database of Chinese Scientific and the Technical Periodicals, and the Chinese Biomedical Database. The literature search was performed on September 16, 2016. There was no language limitation criteria. The literature search was performed using the following Medical Subject Headings (MeSH) or keywords: (Glutathione S-transferase T1 or Glutathione S-transferase or GSTT1 or Glutathione S-transferases or GSTs or GSTT or GST*) and (inflammatory bowel disease or Crohn's disease or ulcerative colitis). The literature search was conducted by two authors (Jun Qian and Zhangfa Song) and they reviewed the initial search results before including or excluding studies. The authors reached consensus on all possible eligible studies after reviewing the search outcomes.
The eligible studies met the following criteria: A) study of the GSTT1 null genotype impact on the susceptibility to CD or UC; B) cohort studies, cross-section studies, or case-control studies; and C) provided data for calculating the odds ratio (OR) of the association. The case-only studies and reviews were excluded from the analysis.
Data extraction and quality assessment
Two authors (Jun Qian and Zhangfa Song) independently extracted data from all included studies. The following information was collected: study ID, area, ethnicity, demographic characteristics of cases and controls, numbers of cases and controls, and distributions of GSTT1 null genotype in both cases and controls.
The study quality assessment was performed using the Newcastle-Ottawa scale (NOS) [25] . The NOS criteria state studies with 7-9 points are defined as high quality and the studies with 4-6 points are defined as middle quality. The remaining studies were considered poor quality [25] . A Hardy-Weinberg Equilibrium (HWE) is usually used to test the quality of selected controls by analysing the distributions of three genotypes of single nucleotide polymorphisms (SNP). However, this study examined the GSTT1 null genotype, which has two genotypes (Null or Non-null). Thus, the HWE was not used to test the quality of the selected controls.
Statistical methods
The pooled OR with 95% confidence interval (95%CI) was used to assess the association. The heterogeneity was assessed using both the Q-statistic test and the I 2 method [26, 27] . A value for I 2 greater than 40% indicates obvious heterogeneity and a meta-analysis using a random-effect model should be performed [28] . When I 2 is less than 40% the meta-analysis should use a fixed-effect model [29] . All subgroup analyses were performed for ethnicity and type of IBD. A Galbraith plot was adopted to show the studies that result in heterogeneity [30] . The presence of publication bias was investigated by funnel plots with the Egger regression method [31] . Stata version 11.0 was used in the meta-analysis. A P-value less than 0.05 was considered statistically significant.
Results
Study characteristics
The literature search identified 157 individual studies. There were 146 studies excluded after reviewing the abstracts and full texts. Thus, 11 publications were included in the metaanalysis [17] [18] [19] [20] [21] [22] [23] [24] [32] [33] [34] . There were five publications that assessed the association of the GSTT1 null genotype with CD and five publications for UC. Thus, we extracted 10 individual studies [17] [18] [19] [20] [21] . As a result, 16 individual studies from 11 publications were included in the analysis. These studies involved a total of 3366 cases and 6013 controls [17] [18] [19] [20] [21] [22] [23] [24] [32] [33] [34] . The main characteristics of the 16 included studies in our meta-analysis are shown in Table 1 . There were 11 studies that assessed the association between the GSTT1 null genotype and UC. There were 5 studies that assessed the association between the GSTT1 null genotype and CD (Table 1 ). In addition, 9 studies were from Caucasian countries and 5 studies were from Asian countries. There were two studies were from African countries ( Table 1 ). The outcomes of the NOS quality assessment are shown in Table 1 . The majority of the included studies were middle quality (Table 1) .
Meta-analysis
There was heterogeneity observed in the meta-analysis of all 16 studies on IBD (I 2 = 90.4%). The Galbraith plot showed the studies by Mittal and Broekman were the main sources of heterogeneity (Fig. 1) . The I 2 value of heterogeneity decreased from 90.4% to 54.6% after excluding those two studies.
The meta-analysis of all 16 studies suggested the GSTT1 null genotype significantly increased susceptibility to IBD (OR = 1.98, 95%CI 1.39-2.84, P < 0.001) (Fig. 2) . The exclusion of the studies by Mittal and Broekman still showed the GSTT1 null genotype led Table 1 . Characteristics of included studies on the association between GSTT1 null genotype and IBD. (*UC, ulcerative colitis; CD, Crohn's disease) to a significantly increased susceptibility to IBD (OR = 1.55, 95%CI 1.30-1.86, P < 0.001; I 2 = 54.6%). The subgroup analysis by ethnicity further identified a significant association between the GSTT1 null genotype and IBD in Caucasians (OR = 1.34, 95%CI 1.09-1.64, P = 0.005; I 2 = 43.7%), Asians (OR = 1.81, 95%CI 1.46-2.25, P < 0.001; I 2 = 14.0%) and Africans (OR = 2.88, 95%CI 1.67-4.98, P < 0.001; I 2 = 0%). There was heterogeneity observed in the meta-analysis of 11 studies on UC (I 2 = 92.3%). The GSTT1 null genotype was significantly associated with UC (OR = 1.96, 95%CI 1.23-3.12, P = 0.004) (Fig. 2) . We adjusted the heterogeneity by excluding the studies from Mittal and Broekman. The results show the GSTT1 null genotype was still significantly associated with UC (OR = 1.63, 95%CI 1.29-2.06, P < 0.0001; I 2 = 60.6%) (Fig. 3 ). There was also heterogeneity observed in the meta-analysis of 5 studies on CD (I 2 = 84.4%). The GSTT1 null genotype was significantly associated with CD (OR = 2.01, 95%CI 1.10-3.67, P = 0.022) (Fig. 2) . We adjusted the heterogeneity by excluding the study from Mittal and found the GSTT1 null genotype was still significantly associated with CD (OR = 1.40, 95%CI 1.05-1.88, P = 0.023; I 2 = 41.8%) (Fig. 3) . null genotype also significantly increased susceptibility to UC (OR = 1.96, P = 0.004) and CD (OR = 2.01, P = 0.022) (Fig. 2) . The GSTT1 null genotype significantly increased susceptibility to UC or CD after adjusting the heterogeneity (Fig. 3) . Therefore, the meta-analysis provided strong evidence indicating the GSTT1 null genotype is a genetic susceptibility factor for IBD, UC, and CD. Genetic factors are recognized as important contributors to IBD pathogenesis [35, 36] . Therefore, the identification of genetic factors associated with IBD will aid in the development of novel therapeutic targets [37] . Genome-wide association studies (GWAS) have found more than 200 genetic risk loci for IBD [38, 39] . However, the GSTT1 null genotype was not analysed in prior GWAS studies and it was unclear whether this genotype was associated with IBD. This meta-analysis pooled data from 16 individual studies and the findings suggest the GSTT1 null genotype was a genetic risk factor for both UC and CD. These results indicate the GSTT1 null genotype is possibly a novel therapeutic target.
Oxidative stress caused by increased reactive oxygen species (ROS) is an important pathogenic factor in IBD. The overproduction of ROS has been found in the inflamed mucosa of IBD patients [16] . Excessive oxidative free radicals can result in cellular stress and facilitate inflammatory reactions, which further result in the development of UC or CD [40] [41] [42] . GSTs are enzymes with important roles in the detoxification of electrophilic compounds including ROS [12] . GSTs can eliminate oxidative free radicals by glutathione and play a critical role in protecting cells against the oxidative free radicals generated by oxidative stress. The GSTT1 null genotype can lead to decreased activity of GSTs enzymes, which further increases the risk of oxidative stress and UC or CD. Therefore, the decreased GSTs activity in individuals with the GSTT1 null genotype could explain part of the mechanism underling the association between the GSTT1 null genotype and IBD. However, the mechanism underling the association is still poorly understood and additional studies are needed.
The findings in our meta-analysis provide strong epidemiological evidence for the role of the GSTT1 null genotype in UC and CD. Previous studies also have suggested that several GSTs genotypes are associated with poor clinical response to azathioprine in IBD patients. This result indicates the important roles of GSTs in the development of IBD [43, 44] . However, it is still unclear whether the GSTT1 null genotype is associated with clinical response or outcomes in IBD patients and future studies are needed to explore this possibility.
There are several limitations of the meta-analysis to address. First, heterogeneity was detected in the meta-analysis of all included studies. The explanations for the heterogeneity may be the different eligibility criteria for cases or controls, or the different races of studied patients. Second, the number of published studies was not sufficient and most studies had a small sample size. There is no particular number of studies that would be considered sufficient for a meta-analysis. However, it has been conventionally considered appropriate if the number of included studies is no less than 10, especially if there is an assessment of publication bias. Additional studies are needed to further explore this association. Finally, the pooled ORs were based on unadjusted estimates and there are potentially confounding factors that were not excluded by adjustment. Gene-disease association studies usually report unadjusted ORs to assess the associations. However, studies may report adjusted ORs to provide a more appropriate estimation of the associations. In the present meta-analysis, the majority of included studies were case-control studies and reported unadjusted Ors. Therefore, we were unable to analyse the adjusted estimates.
In summary, our results show the GSTT1 null genotype is significantly associated with IBD and the GSTT1 null genotype is a risk factor for both UC and CD. Additional studies with more participants are warranted to further explore these associations.
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